80_FR_33079 80 FR 32968 - Proposed collection; 60-day comment request Information Program on Clinical Trials: Maintaining a Registry and Results Databank (NLM) [email protected] Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Information Program on Clinical Trials: Maintaining a Registry and Results Databank (NLM), 0925-0586, Expiration Date: 08/31/2015, EXTENSION, National Library of Medicine (NLM), National Institutes of Health (NIH). Need and Use of Information Collection: The National Institutes of Health operates ClinicalTrials.gov, which was established as a clinical trial registry under section 113 of the Food and Drug Administration Modernization Act of 1997 (Pub. L. 105-115) and was expanded to include a results data bank by Title VIII of the Food and Drug Administration Amendments Act of 2007 (FDAAA). ClinicalTrials.gov collects registration and results information for clinical trials and other types of clinical studies (e.g., observational studies and patient registries) with the objectives of enhancing patient enrollment and providing a mechanism for tracking subsequent progress of clinical studies, to the benefit of public health. It is widely used by patients, physicians, and medical researchers; in particular those involved in clinical research. While many clinical studies are registered and submit results information voluntarily, FDAAA requires the registration of certain applicable clinical trials of drugs and devices and the submission of results information for completed applicable clinical trials of drugs and devices that are approved, licensed, or cleared by the Food and Drug Administration. Beginning in 2009, results information was required to include information about serious and frequent adverse events. This extension request does not include any changes to the information submission requirements for ClinicalTrials.gov that were proposed in the Notice of Proposed Rulemaking on Clinical Trial Registration and Results Submission that was issued on November 21, 2014 and for which the public comment period closed on March 23, 2015 (79 FR 225, Nov. 21, 2014). The NIH is continuing to review submitted public comments as it prepares the final rule. The NIH will make any corresponding changes to the ClinicalTrials.gov information collection via separate procedure. OMB approval is requested for 3 years. The total estimated annualized cost to respondents is $49,399,851. The total estimated annualized burden hours are 682,535."> [email protected] Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Information Program on Clinical Trials: Maintaining a Registry and Results Databank (NLM), 0925-0586, Expiration Date: 08/31/2015, EXTENSION, National Library of Medicine (NLM), National Institutes of Health (NIH). Need and Use of Information Collection: The National Institutes of Health operates ClinicalTrials.gov, which was established as a clinical trial registry under section 113 of the Food and Drug Administration Modernization Act of 1997 (Pub. L. 105-115) and was expanded to include a results data bank by Title VIII of the Food and Drug Administration Amendments Act of 2007 (FDAAA). ClinicalTrials.gov collects registration and results information for clinical trials and other types of clinical studies (e.g., observational studies and patient registries) with the objectives of enhancing patient enrollment and providing a mechanism for tracking subsequent progress of clinical studies, to the benefit of public health. It is widely used by patients, physicians, and medical researchers; in particular those involved in clinical research. While many clinical studies are registered and submit results information voluntarily, FDAAA requires the registration of certain applicable clinical trials of drugs and devices and the submission of results information for completed applicable clinical trials of drugs and devices that are approved, licensed, or cleared by the Food and Drug Administration. Beginning in 2009, results information was required to include information about serious and frequent adverse events. This extension request does not include any changes to the information submission requirements for ClinicalTrials.gov that were proposed in the Notice of Proposed Rulemaking on Clinical Trial Registration and Results Submission that was issued on November 21, 2014 and for which the public comment period closed on March 23, 2015 (79 FR 225, Nov. 21, 2014). The NIH is continuing to review submitted public comments as it prepares the final rule. The NIH will make any corresponding changes to the ClinicalTrials.gov information collection via separate procedure. OMB approval is requested for 3 years. The total estimated annualized cost to respondents is $49,399,851. The total estimated annualized burden hours are 682,535." /> [email protected] Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Information Program on Clinical Trials: Maintaining a Registry and Results Databank (NLM), 0925-0586, Expiration Date: 08/31/2015, EXTENSION, National Library of Medicine (NLM), National Institutes of Health (NIH). Need and Use of Information Collection: The National Institutes of Health operates ClinicalTrials.gov, which was established as a clinical trial registry under section 113 of the Food and Drug Administration Modernization Act of 1997 (Pub. L. 105-115) and was expanded to include a results data bank by Title VIII of the Food and Drug Administration Amendments Act of 2007 (FDAAA). ClinicalTrials.gov collects registration and results information for clinical trials and other types of clinical studies (e.g., observational studies and patient registries) with the objectives of enhancing patient enrollment and providing a mechanism for tracking subsequent progress of clinical studies, to the benefit of public health. It is widely used by patients, physicians, and medical researchers; in particular those involved in clinical research. While many clinical studies are registered and submit results information voluntarily, FDAAA requires the registration of certain applicable clinical trials of drugs and devices and the submission of results information for completed applicable clinical trials of drugs and devices that are approved, licensed, or cleared by the Food and Drug Administration. Beginning in 2009, results information was required to include information about serious and frequent adverse events. This extension request does not include any changes to the information submission requirements for ClinicalTrials.gov that were proposed in the Notice of Proposed Rulemaking on Clinical Trial Registration and Results Submission that was issued on November 21, 2014 and for which the public comment period closed on March 23, 2015 (79 FR 225, Nov. 21, 2014). The NIH is continuing to review submitted public comments as it prepares the final rule. The NIH will make any corresponding changes to the ClinicalTrials.gov information collection via separate procedure. OMB approval is requested for 3 years. The total estimated annualized cost to respondents is $49,399,851. The total estimated annualized burden hours are 682,535." />

80 FR 32968 - Proposed collection; 60-day comment request Information Program on Clinical Trials: Maintaining a Registry and Results Databank (NLM)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 111 (June 10, 2015)

Page Range32968-32969
FR Document2015-14169

In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Library of Medicine (NLM), National Institutes of Health (NIH), will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. This summary describes the existing information collection at ClinicalTrials.gov, for which an extension is requested; it does not include any changes to the information collection that were proposed in the Notice of Proposed Rulemaking on Clinical Trial Registration and Results Submission that was issued on November 21, 2014 (79 FR 225, Nov. 21, 2014). Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. To Submit Comments and For Further Information: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: David Sharlip, Office of Administrative and Management Analysis Services, National Library of Medicine, Building 38A, Room B2N12, 8600 Rockville Pike, Bethesda, MD 20894, or call non-toll-free number (301) 402-9680, or Email your request, including your address to: [email protected] Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Information Program on Clinical Trials: Maintaining a Registry and Results Databank (NLM), 0925-0586, Expiration Date: 08/31/2015, EXTENSION, National Library of Medicine (NLM), National Institutes of Health (NIH). Need and Use of Information Collection: The National Institutes of Health operates ClinicalTrials.gov, which was established as a clinical trial registry under section 113 of the Food and Drug Administration Modernization Act of 1997 (Pub. L. 105-115) and was expanded to include a results data bank by Title VIII of the Food and Drug Administration Amendments Act of 2007 (FDAAA). ClinicalTrials.gov collects registration and results information for clinical trials and other types of clinical studies (e.g., observational studies and patient registries) with the objectives of enhancing patient enrollment and providing a mechanism for tracking subsequent progress of clinical studies, to the benefit of public health. It is widely used by patients, physicians, and medical researchers; in particular those involved in clinical research. While many clinical studies are registered and submit results information voluntarily, FDAAA requires the registration of certain applicable clinical trials of drugs and devices and the submission of results information for completed applicable clinical trials of drugs and devices that are approved, licensed, or cleared by the Food and Drug Administration. Beginning in 2009, results information was required to include information about serious and frequent adverse events. This extension request does not include any changes to the information submission requirements for ClinicalTrials.gov that were proposed in the Notice of Proposed Rulemaking on Clinical Trial Registration and Results Submission that was issued on November 21, 2014 and for which the public comment period closed on March 23, 2015 (79 FR 225, Nov. 21, 2014). The NIH is continuing to review submitted public comments as it prepares the final rule. The NIH will make any corresponding changes to the ClinicalTrials.gov information collection via separate procedure. OMB approval is requested for 3 years. The total estimated annualized cost to respondents is $49,399,851. The total estimated annualized burden hours are 682,535.

Federal Register, Volume 80 Issue 111 (Wednesday, June 10, 2015) 
[Federal Register Volume 80, Number 111 (Wednesday, June 10, 2015)]
[Notices]
[Pages 32968-32969]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-14169]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed collection; 60-day comment request Information Program 
on Clinical Trials: Maintaining a Registry and Results Databank (NLM)

SUMMARY: In compliance with the requirement of section 3506(c)(2)(A) of 
the Paperwork Reduction Act of 1995, for opportunity for public comment 
on proposed data collection projects, the National Library of Medicine 
(NLM), National Institutes of Health (NIH), will publish periodic 
summaries of proposed projects to be submitted to the Office of 
Management and Budget (OMB) for review and approval. This summary 
describes the existing information collection at ClinicalTrials.gov, 
for which an extension is requested; it does not include any changes to 
the information collection that were proposed in the Notice of Proposed 
Rulemaking on Clinical Trial Registration and Results Submission that 
was issued on November 21, 2014 (79 FR 225, Nov. 21, 2014).
    Written comments and/or suggestions from the public and affected 
agencies are invited on one or more of the following points: (1) 
Whether the proposed collection of information is necessary for the 
proper performance of the function of the agency, including whether the 
information will have practical utility; (2) The accuracy of the 
agency's estimate of the burden of the proposed collection of 
information, including the validity of the methodology and assumptions 
used; (3) Ways to enhance the quality, utility, and clarity of the 
information to be collected; and (4) Ways to minimize the burden of the 
collection of information on those who are to respond, including the 
use of appropriate automated, electronic, mechanical, or other 
technological collection techniques or other forms of information 
technology.
    To Submit Comments and For Further Information: To obtain a copy of 
the data collection plans and instruments, submit comments in writing, 
or request more information on the proposed project, contact: David 
Sharlip, Office of Administrative and Management Analysis Services, 
National Library of Medicine, Building 38A, Room B2N12, 8600 Rockville 
Pike, Bethesda, MD 20894, or call non-toll-free number (301) 402-9680, 
or Email your request, including your address to: [email protected] 
Formal requests for additional plans and instruments must be requested 
in writing.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 60 days 
of the date of this publication.
    Proposed Collection: Information Program on Clinical Trials: 
Maintaining a Registry and Results Databank (NLM), 0925-0586, 
Expiration Date: 08/31/2015, EXTENSION, National Library of Medicine 
(NLM), National Institutes of Health (NIH).
    Need and Use of Information Collection: The National Institutes of 
Health operates ClinicalTrials.gov, which was established as a clinical 
trial registry under section 113 of the Food and Drug Administration 
Modernization Act of 1997 (Pub. L. 105-115) and was expanded to include 
a results data bank by Title VIII of the Food and Drug Administration 
Amendments Act of 2007 (FDAAA). ClinicalTrials.gov collects 
registration and results information for clinical trials and other 
types of clinical studies (e.g., observational studies and patient 
registries) with the objectives of enhancing patient enrollment and 
providing a mechanism for tracking subsequent progress of clinical 
studies, to the benefit of public health. It is widely used by 
patients, physicians, and medical researchers; in particular those 
involved in clinical research. While many clinical studies are 
registered and submit results information voluntarily, FDAAA requires 
the registration of certain applicable clinical trials of drugs and 
devices and the submission of results information for completed 
applicable clinical trials of drugs and devices that are approved, 
licensed, or cleared by the Food and Drug Administration. Beginning in 
2009, results information was required to include information about 
serious and frequent adverse events.
    This extension request does not include any changes to the 
information submission requirements for ClinicalTrials.gov that were 
proposed in the Notice of Proposed Rulemaking on Clinical Trial 
Registration and Results Submission that was issued on November 21, 
2014 and for which the public comment period closed on March 23, 2015 
(79 FR 225, Nov. 21, 2014). The NIH is continuing to review submitted 
public comments as it prepares the final rule. The NIH will make any 
corresponding changes to the ClinicalTrials.gov information collection 
via separate procedure.
    OMB approval is requested for 3 years. The total estimated 
annualized cost to respondents is $49,399,851. The total estimated 
annualized burden hours are 682,535.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of
                 Submission type                     Number of     response per    Average time     Annual hour
                                                    respondents     respondent     per response       burden
----------------------------------------------------------------------------------------------------------------
PRS Account.....................................           5,700               1           15/60           1,425
Initial Registration............................          23,000               1               7         161,000
Updates.........................................          23,000               8               2         368,000
Initial Results.................................           3,700               1              25          92,500
Updates.........................................           3,700               2               8          59,200

[[Page 32969]]

 
Certification to Delay Results..................             700               1           30/60             350
Extension Request...............................              30               1               2              60
                                                 ---------------------------------------------------------------
    Total.......................................          33,130  ..............  ..............         682,535
----------------------------------------------------------------------------------------------------------------


    Dated: June 4, 2015.
David Sharlip,
Project Clearance Liaison, NLM, NIH.
[FR Doc. 2015-14169 Filed 6-9-15; 8:45 am]
BILLING CODE 4140-01-P

32968 Federal Register / Vol. 80, No. 111 / Wednesday, June 10, 2015 / Notices Contact Person: Joseph Thomas Peterson, information collection that were Health operates ClinicalTrials.gov, Ph.D., Scientific Review Officer, Center for proposed in the Notice of Proposed which was established as a clinical trial Scientific Review, National Institutes of Rulemaking on Clinical Trial registry under section 113 of the Food Health, 6701 Rockledge Drive, Room 4118, Registration and Results Submission and Drug Administration Modernization MSC 7814, Bethesda, MD 20892, 301–408– 9694, petersonjt@csr.nih.gov. that was issued on November 21, 2014 Act of 1997 (Pub. L. 105–115) and was Name of Committee: Center for Scientific (79 FR 225, Nov. 21, 2014). expanded to include a results data bank Review Special Emphasis Panel; Small Written comments and/or suggestions by Title VIII of the Food and Drug Business: Radiation Therapy and Biology from the public and affected agencies Administration Amendments Act of SBIR/STTR. are invited on one or more of the 2007 (FDAAA). ClinicalTrials.gov Date: July 8–9, 2015. following points: (1) Whether the collects registration and results Time: 8 a.m. to 5 p.m. proposed collection of information is information for clinical trials and other Agenda: To review and evaluate grant necessary for the proper performance of applications. types of clinical studies (e.g., the function of the agency, including observational studies and patient Place: National Institutes of Health, 6701 whether the information will have Rockledge Drive, Bethesda, MD 20892, registries) with the objectives of (Virtual Meeting). practical utility; (2) The accuracy of the enhancing patient enrollment and Contact Person: Bo Hong, Ph.D., Scientific agency’s estimate of the burden of the providing a mechanism for tracking Review Officer, Center for Scientific Review, proposed collection of information, including the validity of the subsequent progress of clinical studies, National Institutes of Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD methodology and assumptions used; (3) to the benefit of public health. It is 20892, 301–996–6208, hongb@csr.nih.gov. Ways to enhance the quality, utility, and widely used by patients, physicians, (Catalogue of Federal Domestic Assistance clarity of the information to be and medical researchers; in particular Program Nos. 93.306, Comparative Medicine; collected; and (4) Ways to minimize the those involved in clinical research. 93.333, Clinical Research, 93.306, 93.333, burden of the collection of information While many clinical studies are 93.337, 93.393–93.396, 93.837–93.844, registered and submit results on those who are to respond, including 93.846–93.878, 93.892, 93.893, National information voluntarily, FDAAA Institutes of Health, HHS) the use of appropriate automated, electronic, mechanical, or other requires the registration of certain Dated: June 5, 2015. technological collection techniques or applicable clinical trials of drugs and Anna Snouffer, other forms of information technology. devices and the submission of results Deputy Director, Office of Federal Advisory To Submit Comments and For Further information for completed applicable Committee Policy. Information: To obtain a copy of the clinical trials of drugs and devices that [FR Doc. 2015–14186 Filed 6–9–15; 8:45 am] data collection plans and instruments, are approved, licensed, or cleared by the BILLING CODE 4140–01–P submit comments in writing, or request Food and Drug Administration. more information on the proposed Beginning in 2009, results information project, contact: David Sharlip, Office of was required to include information DEPARTMENT OF HEALTH AND Administrative and Management about serious and frequent adverse HUMAN SERVICES Analysis Services, National Library of events. Medicine, Building 38A, Room B2N12, This extension request does not National Institutes of Health 8600 Rockville Pike, Bethesda, MD include any changes to the information Proposed collection; 60-day comment 20894, or call non-toll-free number (301) submission requirements for request Information Program on 402–9680, or Email your request, ClinicalTrials.gov that were proposed in Clinical Trials: Maintaining a Registry including your address to: sharlipd@ the Notice of Proposed Rulemaking on and Results Databank (NLM) mail.nih.gov Formal requests for Clinical Trial Registration and Results additional plans and instruments must Submission that was issued on SUMMARY: In compliance with the be requested in writing. November 21, 2014 and for which the requirement of section 3506(c)(2)(A) of Comment Due Date: Comments the Paperwork Reduction Act of 1995, public comment period closed on March regarding this information collection are 23, 2015 (79 FR 225, Nov. 21, 2014). The for opportunity for public comment on best assured of having their full effect if proposed data collection projects, the NIH is continuing to review submitted received within 60 days of the date of public comments as it prepares the final National Library of Medicine (NLM), this publication. National Institutes of Health (NIH), will rule. The NIH will make any Proposed Collection: Information publish periodic summaries of proposed corresponding changes to the Program on Clinical Trials: Maintaining projects to be submitted to the Office of ClinicalTrials.gov information a Registry and Results Databank (NLM), Management and Budget (OMB) for collection via separate procedure. 0925–0586, Expiration Date: 08/31/ review and approval. This summary 2015, EXTENSION, National Library of OMB approval is requested for 3 describes the existing information Medicine (NLM), National Institutes of years. The total estimated annualized collection at ClinicalTrials.gov, for Health (NIH). cost to respondents is $49,399,851. The which an extension is requested; it does Need and Use of Information total estimated annualized burden hours not include any changes to the Collection: The National Institutes of are 682,535. ESTIMATED ANNUALIZED BURDEN HOURS asabaliauskas on DSK5VPTVN1PROD with NOTICES Number of Average Annual Number of Submission type response per time per hour respondents respondent response burden PRS Account ................................................................................................... 5,700 1 15/60 1,425 Initial Registration ............................................................................................ 23,000 1 7 161,000 Updates ............................................................................................................ 23,000 8 2 368,000 Initial Results ................................................................................................... 3,700 1 25 92,500 Updates ............................................................................................................ 3,700 2 8 59,200 VerDate Sep<11>2014 16:46 Jun 09, 2015 Jkt 235001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\10JNN1.SGM 10JNN1

Federal Register / Vol. 80, No. 111 / Wednesday, June 10, 2015 / Notices 32969 ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of Average Annual Number of Submission type response per time per hour respondents respondent response burden Certification to Delay Results .......................................................................... 700 1 30/60 350 Extension Request ........................................................................................... 30 1 2 60 Total .......................................................................................................... 33,130 ........................ ........................ 682,535 Dated: June 4, 2015. Contact Person: Peter J. Kozel, Ph.D., Agenda: To review and evaluate grant David Sharlip, Scientific Review Officer, Center for applications. Scientific Review, National Institutes of Place: St. Gregory Hotel, 2033 M Street Project Clearance Liaison, NLM, NIH. Health, 6701 Rockledge Drive, Room 3139, NW., Washington, DC 20036. [FR Doc. 2015–14169 Filed 6–9–15; 8:45 am] Bethesda, MD 20892, 301–435–1116, kozelp@ Contact Person: Mark P. Rubert, Ph.D., BILLING CODE 4140–01–P mail.nih.gov. Scientific Review Officer, Center for Name of Committee: Center for Scientific Scientific Review, National Institutes of Review Special Emphasis Panel; Member Health, 6701 Rockledge Drive, Room 5218, DEPARTMENT OF HEALTH AND Conflict: Glioblastomas, Multiple Sclerosis, MSC 7852, Bethesda, MD 20892, 301–806– HUMAN SERVICES Viruses, and Psychiatric Disorders. 6596, rubertm@csr.nih.gov. Date: June 30, 2015. (Catalogue of Federal Domestic Assistance National Institutes of Health Time: 10:00 a.m. to 12:00 p.m. Program Nos. 93.306, Comparative Medicine; Agenda: To review and evaluate grant 93.333, Clinical Research, 93.306, 93.333, Center for Scientific Review; Notice of applications. 93.337, 93.393–93.396, 93.837–93.844, Closed Meetings Place: National Institutes of Health, 6701 93.846–93.878, 93.892, 93.893, National Rockledge Drive, Bethesda, MD 20892 Institutes of Health, HHS) Pursuant to section 10(d) of the (Telephone Conference Call). Dated: June 4, 2015. Federal Advisory Committee Act, as Contact Person: Samuel C Edwards, Ph.D., amended (5 U.S.C. App.), notice is IRG CHIEF, Center for Scientific Review, Carolyn Baum, hereby given of the following meetings. National Institutes of Health, 6701 Rockledge Program Analyst, Office of Federal Advisory The meetings will be closed to the Drive, Room 5210, MSC 7846, Bethesda, MD Committee Policy. public in accordance with the 20892, (301) 435–1246, edwardss@ [FR Doc. 2015–14170 Filed 6–9–15; 8:45 am] csr.nih.gov. provisions set forth in sections BILLING CODE 4140–01–P 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR14–066: as amended. The grant applications and Limited Competition: Specific Pathogen Ffee the discussions could disclose DEPARTMENT OF HEALTH AND Macaque Colonies. confidential trade secrets or commercial Date: June 30, 2015. HUMAN SERVICES property such as patentable material, Time: 1:00 p.m. to 4:00 p.m. and personal information concerning Agenda: To review and evaluate grant National Institutes of Health individuals associated with the grant applications. Place: National Institutes of Health, 6701 Government-Owned Inventions; applications, the disclosure of which Availability for Licensing would constitute a clearly unwarranted Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). AGENCY: National Institutes of Health, invasion of personal privacy. Contact Person: Robert Freund, Ph.D., Name of Committee: Center for Scientific Scientific Review Officer, Center for HHS. Review Special Emphasis Panel; Member Scientific Review, National Institutes of ACTION: Notice. Conflict: Corneal Diseases, Membrane Health, 6701 Rockledge Drive, Room 5216, Transport, and Ocular Cancer. MSC 7852, Bethesda, MD 20892, 301–435– SUMMARY: The inventions listed below Date: June 22, 2015. 1050, freundr@csr.nih.gov. are owned by an agency of the U.S. Time: 10:00 a.m. to 12:00 p.m. Name of Committee: Center for Scientific Government and are available for Agenda: To review and evaluate grant Review Special Emphasis Panel; Small licensing in the U.S. in accordance with applications. Business: Cancer Drug Development and 35 U.S.C. 209 and 37 CFR part 404 to Place: National Institutes of Health, 6701 Therapeutics. achieve expeditious commercialization Rockledge Drive, Bethesda, MD 20892 Date: July 8–9, 2015. of results of federally-funded research (Telephone Conference Call). Time: 8:00 a.m. to 5:00 p.m. and development. Foreign patent Contact Person: Alessandra C Rovescalli, Agenda: To review and evaluate grant Ph.D., Scientific Review Officer, National applications are filed on selected applications. Institutes of Health, Center for Scientific Place: National Institutes of Health, 6701 inventions to extend market coverage Review, 6701 Rockledge Drive, Rm 5205 Rockledge Drive, Bethesda, MD 20892 for companies and may also be available MSC7846, Bethesda, MD 20892, (301) 435– (Virtual Meeting). for licensing. 1021, rovescaa@mail.nih.gov. Contact Person: Lilia Topol, Ph.D., FOR FURTHER INFORMATION CONTACT: Name of Committee: Healthcare Delivery Scientific Review Officer, Center for Licensing information and copies of the and Methodologies Integrated Review Group; Scientific Review, National Institutes of U.S. patent applications listed below asabaliauskas on DSK5VPTVN1PROD with NOTICES Biostatistical Methods and Research Design Health, 6701 Rockledge Drive, Room 6192, may be obtained by writing to the Study Section. MSC 7804, Bethesda, MD 20892, 301–451– 0131, ltopol@mail.nih.gov. indicated licensing contact at the Office Date: June 26, 2015. of Technology Transfer, National Time: 8:00 a.m. to 5:00 p.m. Name of Committee: AIDS and Related Agenda: To review and evaluate grant Research Integrated Review Group; Institutes of Health, 6011 Executive applications. Behavioral and Social Consequences of HIV/ Boulevard, Suite 325, Rockville, Place: Embassy Suites at the Chevy Chase AIDS Study Section. Maryland 20852–3804; telephone: 301– Pavilion, 4300 Military Road NW., Date: July 9–10, 2015. 496–7057; fax: 301–402–0220. A signed Washington, DC 20015. Time: 8:00 a.m. to 5:00 p.m. Confidential Disclosure Agreement will VerDate Sep<11>2014 16:46 Jun 09, 2015 Jkt 235001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\10JNN1.SGM 10JNN1


Document Created: 2015-12-15 15:17:39
Document Modified: 2015-12-15 15:17:39
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesComments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication.
FR Citation80 FR 32968 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR